Meng Y - Search Results

1

Pralsetinib as neoadjuvant therapy for RET-Altered differentiated thyroid cancer: Two case reports.

Huang NS, Chen JY, Meng Y, Li QL, Ji QH, Wang Y. Huang NS, et al. Among authors: meng y. Oral Oncol. 2024 Sep 21;159:107014. doi: 10.1016/j.oraloncology.2024.107014. Online ahead of print. Oral Oncol. 2024. PMID: 39306936

2

Pralsetinib for the treatment of a RET-positive advanced non-small-cell lung cancer patient harboring both ANK-RET and CCDC6-RET fusions with coronary heart disease: a case report.

Meng Y, Li L, Wang H, Chen X, Yue Y, Wang M, Meng L, Li B, Li X. Meng Y, et al. Among authors: meng l. Ann Transl Med. 2022 Apr;10(8):496. doi: 10.21037/atm-22-1237. Ann Transl Med. 2022. PMID: 35571397 Free PMC article.

3

The Treatment Status of Patients in NSCLC With RET Fusion Under the Prelude of Selective RET-TKI Application in China: A Multicenter Retrospective Research.

Meng Y, Yang Y, Fang Y, Lin X, Xie X, Deng H, Wu J, Zhou M, Sun N, Xie Z, Liu M, Ouyang M, Qin Y, Su C, Zhou C. Meng Y, et al. Front Oncol. 2022 May 24;12:864367. doi: 10.3389/fonc.2022.864367. eCollection 2022. Front Oncol. 2022. PMID: 35692799 Free PMC article.

4

Case report: Response to tepotinib in Chinese non-small cell lung cancer patients harboring METex14 skipping with varying features.

Meng Y, Zhou W, Li C, Zhou X, Li X, Li L, Fu Q, Huang J, Yue Y, Shen X, Yang L, Wang M. Meng Y, et al. Front Oncol. 2024 Jul 2;14:1383964. doi: 10.3389/fonc.2024.1383964. eCollection 2024. Front Oncol. 2024. PMID: 39015492 Free PMC article.

5

Development and application of a sensitive droplet digital PCR-based method to detect tilapia parvovirus.

Zhao H, Zhou Y, Fan Y, Jiang N, Meng Y, Li Y, Xue M, Xu C, Guo W, Liu W. Zhao H, et al. Among authors: meng y. J Fish Dis. 2023 Mar;46(3):239-245. doi: 10.1111/jfd.13738. Epub 2023 Jan 2. J Fish Dis. 2023. PMID: 36591869

6

Structural characteristics and antioxidant activity of a low-molecular-weight jujube polysaccharide by ultrasound assisted metal-free Fenton reaction.

Liu Y, Meng Y, Ji H, Guo J, Shi M, Lai F, Ji X. Liu Y, et al. Among authors: meng y. Food Chem X. 2024 Oct 20;24:101908. doi: 10.1016/j.fochx.2024.101908. eCollection 2024 Dec 30. Food Chem X. 2024. PMID: 39507930 Free PMC article.

7

Development and characterization of human T-cell receptor (TCR) alpha and beta clones' library as biological standards and resources for TCR sequencing and engineering.

Wei YC, Pospiech M, Meng Y, Alachkar H. Wei YC, et al. Among authors: meng y. Biol Methods Protoc. 2024 Sep 5;9(1):bpae064. doi: 10.1093/biomethods/bpae064. eCollection 2024. Biol Methods Protoc. 2024. PMID: 39507623 Free PMC article.

8

Pyroptosis regulation by Salmonella effectors.

Meng Y, Zhang Q, Xu M, Ding K, Yu Z, Li J. Meng Y, et al. Front Immunol. 2024 Oct 23;15:1464858. doi: 10.3389/fimmu.2024.1464858. eCollection 2024. Front Immunol. 2024. PMID: 39507539 Free PMC article. Review.

9

Cerebral biomimetic nano-drug delivery systems: A frontier strategy for immunotherapy.

Tian H, Yao J, Ba Q, Meng Y, Cui Y, Quan L, Gong W, Wang Y, Yang Y, Yang M, Gao C. Tian H, et al. Among authors: meng y. J Control Release. 2024 Nov 4:S0168-3659(24)00730-2. doi: 10.1016/j.jconrel.2024.10.058. Online ahead of print. J Control Release. 2024. PMID: 39505218 Review.

10

Factors Affecting Distribution and Ecological Risk Assessment of Volatile Organic Compounds (VOCs) in Groundwater of the Huazhou District in Northwestern China.

Meng Y, Li P, Elumalai V. Meng Y, et al. Environ Pollut. 2024 Nov 4:125243. doi: 10.1016/j.envpol.2024.125243. Online ahead of print. Environ Pollut. 2024. PMID: 39505099

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,040 results

Search Page

Filters